Tirzepatide's established adverse effect profile includes gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation) in a substantial proportion of users, particularly during dose escalation
Women are more likely than men to experience chronic fatigue, partly due to biological, hormonal, and social factors
While NAION is rare, the rates among Rybelsus patients were high enough to catch the attention of the medical community and prompt recent changes to the Rybelsus label in Europe
This is a high-risk population, and historically weve had limited data to guide treatment decisions, said Amy Sheer, M.D., M.P.H., an associate professor of medicine and director of the Obesity Medicine Fellowship program at the University of Florida in Gainesville, Florida
What Happens During the Washout Period After you stop your GLP-1 medication, your appetite typically returns within days as receptor signaling normalizes
We do not yet have clear answers on: Long-term safety Optimal dosing strategies Metabolic interactions Effects on weight loss outcomes Some patients who stop GLP-1 treatment may see lost weight return over time